PRESS RELEASE published on 01/30/2023 at 08:39, 1 year 9 months ago DEUTZ AG: DEUTZ enters into cooperation with Daimler Truck to develop and market medium- and heavy-duty engines
PRESS RELEASE published on 01/30/2023 at 08:38, 1 year 9 months ago EQS-Adhoc: DEUTZ AG: DEUTZ reaches agreement with Daimler Truck on acquisition of IP and license rights for medium-duty engines and of license rights for heavy-duty engines
PRESS RELEASE published on 01/19/2023 at 11:00, 1 year 10 months ago DEUTZ AG: ‘POWERING PROGRESS’ strategy program: DEUTZ enginges will continue to keep the world moving
PRESS RELEASE published on 01/18/2023 at 17:00, 1 year 10 months ago DEUTZ AG: Supervisory Board of DEUTZ AG extends term of appointment of CEO Dr. Sebastian C. Schulte by five years
Published on 11/22/2024 at 23:55, 9 hours 20 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 45 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 10 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 45 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 17:53, 15 hours 22 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 20 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 15 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
